The frequency of T-regulatory cells (CD4+CD25+Foxp3+, Tregs) declined also in the advanced MASLD patients (3.57%) compared to the early stage disease (5.16%). The gene discussed is CD4; the disease is metabolic dysfunction-associated steatotic liver disease.